Statistics for Top 9 Results
Filter:
Domain Registration Date Filter
1
With sales turnaround, Astellas projects big growth for Izervay
https://www.fiercepharma.com/pharma/astellas-reports-22-sales-bump-izervay-projects-trend-continue-year
2
Sales of IZERVAY™ (Preliminary Figures) - Astellas
https://newsroom.astellas.com/2025-07-10-Sales-of-IZERVAY-TM-Preliminary-Figures
4
Astellas Reports Q1 FY2025 U.S. Sales of IZERVAY at $110M - AInvest
https://www.ainvest.com/news/astellas-reports-q1-fy2025-sales-izervay-110m-2507/
5
Apellis stock holds Outperform rating at William Blair amid Izervay ...
https://www.investing.com/news/analyst-ratings/apellis-stock-holds-outperform-rating-at-william-blair-amid-izervay-competition-93CH-4129990
6
FDA changes its mind on Astellas' geographic atrophy drug
https://pharmaphorum.com/news/fda-changes-its-mind-astellas-geographic-atrophy-drug
7
Izervay sales rebound in Q2, but Astellas' target still uncertain
https://www.linkedin.com/posts/rahul-gotadki-4a4917119_izervay-astellas-geographicatrophy-activity-7350456893577793536-ze5z
8
New data for Izervay confirm value of Astellas' $5.9 billion punt
https://www.thepharmaletter.com/pharmaceutical/new-data-for-izervay-confirm-value-of-astellas-5-9-billion-punt
9
Astellas takes $760M charge, reveals slowdown for Izervay - Fierce Pharma
https://www.fiercepharma.com/pharma/astellas-charts-path-eye-drug-izervay-after-us-european-regulatory-hurdles-execs